Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 247

1.

Screening for Asymptomatic Coronary Artery Disease in Waitlisted Kidney Transplant Candidates: A Cost-Utility Analysis.

Ying T, Tran A, Webster AC, Klarenbach SW, Gill J, Chadban S, Morton R.

Am J Kidney Dis. 2019 Dec 3. pii: S0272-6386(19)31056-X. doi: 10.1053/j.ajkd.2019.10.001. [Epub ahead of print]

PMID:
31810731
2.

Kidney Health Strategic Clinical Network: Driving positive change to optimize kidney health in Alberta.

Pannu N, Gilmour L, Klarenbach S; Kidney Health Strategic Clinical Network.

CMAJ. 2019 Dec 4;191(Suppl):S39-S41. doi: 10.1503/cmaj.190573. No abstract available.

PMID:
31801764
3.

Economic Evaluation of Extending Medicare Immunosuppressive Drug Coverage for Kidney Transplant Recipients in the Current Era.

Kadatz M, Gill JS, Gill J, Formica RN, Klarenbach S.

J Am Soc Nephrol. 2019 Nov 8. pii: ASN.2019070646. doi: 10.1681/ASN.2019070646. [Epub ahead of print]

PMID:
31704739
4.

Status of care for end stage kidney disease in countries and regions worldwide: international cross sectional survey.

Bello AK, Levin A, Lunney M, Osman MA, Ye F, Ashuntantang GE, Bellorin-Font E, Benghanem Gharbi M, Davison SN, Ghnaimat M, Harden P, Htay H, Jha V, Kalantar-Zadeh K, Kerr PG, Klarenbach S, Kovesdy CP, Luyckx VA, Neuen BL, O'Donoghue D, Ossareh S, Perl J, Rashid HU, Rondeau E, See E, Saad S, Sola L, Tchokhonelidze I, Tesar V, Tungsanga K, Turan Kazancioglu R, Wang AY, Wiebe N, Yang CW, Zemchenkov A, Zhao MH, Jager KJ, Caskey F, Perkovic V, Jindal KK, Okpechi IG, Tonelli M, Feehally J, Harris DC, Johnson DW.

BMJ. 2019 Oct 31;367:l5873. doi: 10.1136/bmj.l5873.

5.

Electronic Advice Request System for Nephrology in Alberta: Pilot Results and Implementation.

Bello AK, Zaidi D, Braam B, Chou S, Courtney M, Deved V, Glassford J, Jindal K, Klarenbach S, Osman M, Scott-Douglas N, Shurraw S, Thompson S, Manns B, Hemmelgarn B, Tonelli M.

Can J Kidney Health Dis. 2019 Oct 4;6:2054358119879778. doi: 10.1177/2054358119879778. eCollection 2019.

6.

Protocol: Improving Access to Specialist Nephrology Care Among Rural/Remote Dwellers of Alberta: The Role of Electronic Consultation in Improving Care for Patients With Chronic Kidney Disease.

Bello A, Zaidi D, Braam B, Courtney M, Glassford J, Jindal K, Klarenbach S, Kurzawa J, Osman M, Scott-Douglas N, Szigety S, Thompson S, Manns B, Hemmelgarn B, Tonelli M.

Can J Kidney Health Dis. 2019 Sep 30;6:2054358119878715. doi: 10.1177/2054358119878715. eCollection 2019.

7.

Barriers and facilitators for implementation of electronic consultations (eConsult) to enhance access to specialist care: a scoping review.

Osman MA, Schick-Makaroff K, Thompson S, Bialy L, Featherstone R, Kurzawa J, Zaidi D, Okpechi I, Habib S, Shojai S, Jindal K, Braam B, Keely E, Liddy C, Manns B, Tonelli M, Hemmelgarn B, Klarenbach S, Bello AK.

BMJ Glob Health. 2019 Sep 13;4(5):e001629. doi: 10.1136/bmjgh-2019-001629. eCollection 2019.

8.

A Cost Analysis and Cost-Utility Analysis of a Community Pharmacist-Led Intervention on Reducing Cardiovascular Risk: The Alberta Vascular Risk Reduction Community Pharmacy Project (RxEACH).

Tam-Tham H, Clement F, Hemmelgarn BR, Manns BJ, Klarenbach SW, Tonelli M, Tsuyuki RT, Al Hamarneh YN, Penko J, Weaver CGW, Au F, Weaver RG, Jones CA, McBrien KA.

Value Health. 2019 Oct;22(10):1128-1136. doi: 10.1016/j.jval.2019.05.012. Epub 2019 Aug 17.

PMID:
31563255
9.

Correction to: Methods for identifying 30 chronic conditions: application to administrative data.

Tonelli M, Wiebe N, Fortin M, Guthrie B, Hemmelgarn BR, James MT, Klarenbach SW, Lewanczuk R, Manns BJ, Ronksley P, Sargious P, Straus S, Quan H; Alberta Kidney Disease Network.

BMC Med Inform Decis Mak. 2019 Sep 4;19(1):177. doi: 10.1186/s12911-019-0900-2.

10.

Clinical Decision Support to Reduce Contrast-Induced Kidney Injury During Cardiac Catheterization: Design of a Randomized Stepped-Wedge Trial.

James MT, Har BJ, Tyrrell BD, Ma B, Faris P, Sajobi TT, Allen DW, Spertus JA, Wilton SB, Pannu N, Klarenbach SW, Graham MM.

Can J Cardiol. 2019 Sep;35(9):1124-1133. doi: 10.1016/j.cjca.2019.06.002. Epub 2019 Jun 7.

11.

Screening to prevent fragility fractures among adults 40 years and older in primary care: protocol for a systematic review.

Gates M, Pillay J, Thériault G, Limburg H, Grad R, Klarenbach S, Korownyk C, Reynolds D, Riva JJ, Thombs BD, Kline GA, Leslie WD, Courage S, Vandermeer B, Featherstone R, Hartling L.

Syst Rev. 2019 Aug 23;8(1):216. doi: 10.1186/s13643-019-1094-5.

12.

Chronic kidney disease of unknown cause in Mexico: The case of Poncitlan, Jalisco.

Garcia-Garcia G, Gutiérrez-Padilla A, Perez-Gomez HR, Chavez-Iñiguez JS, Morraz-Mejia EF, Amador-Jimenez MJ, Romero-Muñoz AC, Gonzalez-De la Peña MDM, Klarenbach S, Tonelli M.

Clin Nephrol. 2019 Aug 9. doi: 10.5414/CNP92S107. [Epub ahead of print]

PMID:
31397272
13.

Kidney care in low- and middle-income countries.

Qarni B, Osman MA, Levin A, Feehally J, Harris D, Jindal K, Olanrewaju TO, Samimi A, Olah ME, Braam B, Sakajiki AM, Lunney M, Wiebe N, Ye F, Jha V, Okpechi I, Courtney M, Klarenbach S, Johnson DW, Bello AK.

Clin Nephrol. 2019 Aug 9. doi: 10.5414/CNP92S104. [Epub ahead of print]

PMID:
31397271
14.

Perioperative Complications During Living Donor Nephrectomy: Results From a Multicenter Cohort Study.

Garcia-Ochoa C, Feldman LS, Nguan C, Monroy-Cuadros M, Arnold J, Boudville N, Cuerden M, Dipchand C, Eng M, Gill J, Gourlay W, Karpinski M, Klarenbach S, Knoll G, Lentine KL, Lok CE, Luke P, Prasad GVR, Sener A, Sontrop JM, Storsley L, Treleaven D, Garg AX; Donor Nephrectomy Outcomes Research (DONOR) Network.

Can J Kidney Health Dis. 2019 Jul 18;6:2054358119857718. doi: 10.1177/2054358119857718. eCollection 2019.

15.

Nonreimbursed Costs Incurred by Living Kidney Donors: A Case Study From Ontario, Canada.

Barnieh L, Klarenbach S, Arnold J, Cuerden M, Knoll G, Lok C, Sontrop JM, Miller M, Ramesh Prasad GV, Przech S, Garg AX; Donor Nephrectomy Outcomes Research (DONOR) Network.

Transplantation. 2019 Jun;103(6):e164-e171. doi: 10.1097/TP.0000000000002685.

PMID:
31246933
16.

Characteristics of Adults With Type 2 Diabetes Mellitus by Category of Chronic Kidney Disease and Presence of Cardiovascular Disease in Alberta Canada: A Cross-Sectional Study.

Tonelli M, Wiebe N, Richard JF, Klarenbach SW, Hemmelgarn BR.

Can J Kidney Health Dis. 2019 Jun 13;6:2054358119854113. doi: 10.1177/2054358119854113. eCollection 2019.

17.

Canadian-Australasian Randomised trial of screening kidney transplant candidates for coronary artery disease-A trial protocol for the CARSK study.

Ying T, Gill J, Webster A, Kim SJ, Morton R, Klarenbach SW, Kelly P, Ramsay T, Knoll GA, Pilmore H, Hughes G, Herzog CA, Chadban S, Gill JS.

Am Heart J. 2019 Aug;214:175-183. doi: 10.1016/j.ahj.2019.05.008. Epub 2019 May 22.

PMID:
31228771
18.

Joint associations of obesity and estimated GFR with clinical outcomes: a population-based cohort study.

Tonelli M, Wiebe N, Kovesdy CP, James MT, Klarenbach SW, Manns BJ, Hemmelgarn BR; Alberta Kidney Disease Network.

BMC Nephrol. 2019 Jun 6;20(1):204. doi: 10.1186/s12882-019-1351-9.

19.

The Cost of Care for People With Chronic Kidney Disease.

Manns B, Hemmelgarn B, Tonelli M, Au F, So H, Weaver R, Quinn AE, Klarenbach S; for Canadians Seeking Solutions and Innovations to Overcome Chronic Kidney Disease.

Can J Kidney Health Dis. 2019 Apr 4;6:2054358119835521. doi: 10.1177/2054358119835521. eCollection 2019.

20.

Incidence and Prognosis of Acute Kidney Diseases and Disorders Using an Integrated Approach to Laboratory Measurements in a Universal Health Care System.

James MT, Levey AS, Tonelli M, Tan Z, Barry R, Pannu N, Ravani P, Klarenbach SW, Manns BJ, Hemmelgarn BR.

JAMA Netw Open. 2019 Apr 5;2(4):e191795. doi: 10.1001/jamanetworkopen.2019.1795.

21.

Statin use and the risk of acute kidney injury in older adults.

Tonelli M, Lloyd AM, Bello AK, James MT, Klarenbach SW, McAlister FA, Manns BJ, Tsuyuki RT, Hemmelgarn BR; Alberta Kidney Disease Network.

BMC Nephrol. 2019 Mar 25;20(1):103. doi: 10.1186/s12882-019-1280-7.

22.

Red cell distribution width associations with clinical outcomes: A population-based cohort study.

Tonelli M, Wiebe N, James MT, Naugler C, Manns BJ, Klarenbach SW, Hemmelgarn BR.

PLoS One. 2019 Mar 13;14(3):e0212374. doi: 10.1371/journal.pone.0212374. eCollection 2019.

23.

Non-reimbursed costs incurred by living kidney donors: A case study from Ontario, Canada.

Barnieh L, Klarenbach S, Arnold J, Cuerden M, Knoll G, Lok C, Sontrop JM, Miller M, Prasad GVR, Przech S, Garg AX; Donor Nephrectomy Outcomes Research (DONOR) Network.

Transplantation. 2019 Mar 1. doi: 10.1097/TP.0000000000002685. [Epub ahead of print]

PMID:
30830039
24.

A cardiac magnetic resonance imaging study of long-term and incident hemodialysis patients.

Thompson RB, Raggi P, Wiebe N, Ugander M, Nickander J, Klarenbach SW, Thompson S, Tonelli M; Alberta Kidney Disease Network.

J Nephrol. 2019 Aug;32(4):615-626. doi: 10.1007/s40620-019-00593-3. Epub 2019 Feb 18.

PMID:
30778918
25.

Global nephrology workforce: gaps and opportunities toward a sustainable kidney care system.

Osman MA, Alrukhaimi M, Ashuntantang GE, Bellorin-Font E, Benghanem Gharbi M, Braam B, Courtney M, Feehally J, Harris DC, Jha V, Jindal K, Johnson DW, Kalantar-Zadeh K, Kazancioglu R, Klarenbach S, Levin A, Lunney M, Okpechi IG, Olanrewaju TO, Perl J, Rashid HU, Rondeau E, Salako BL, Samimi A, Sola L, Tchokhonelidze I, Wiebe N, Yang CW, Ye F, Zemchenkov A, Zhao MH, Bello AK.

Kidney Int Suppl (2011). 2018 Feb;8(2):52-63. doi: 10.1016/j.kisu.2017.10.009. Epub 2018 Jan 19. Review.

26.

Comparison of the Complexity of Patients Seen by Different Medical Subspecialists in a Universal Health Care System.

Tonelli M, Wiebe N, Manns BJ, Klarenbach SW, James MT, Ravani P, Pannu N, Himmelfarb J, Hemmelgarn BR.

JAMA Netw Open. 2018 Nov 2;1(7):e184852. doi: 10.1001/jamanetworkopen.2018.4852. Erratum in: JAMA Netw Open. 2019 Mar 1;2(3):e190147.

27.

Developing key performance indicators for prescription medication systems.

Spackman E, Clement F, Allan GM, Bell CM, Bjerre LM, Blackburn DF, Blais R, Hazlewood G, Klarenbach S, Nicolle LE, Persaud N, Alessi-Severini S, Tierney M, Wijeysundera HC, Manns B.

PLoS One. 2019 Jan 15;14(1):e0210794. doi: 10.1371/journal.pone.0210794. eCollection 2019.

28.

Strategies for incorporating patient-reported outcomes in the care of people with chronic kidney disease (PRO kidney): a protocol for a realist synthesis.

Schick-Makaroff K, Thummapol O, Thompson S, Flynn R, Karimi-Dehkordi M, Klarenbach S, Sawatzky R, Greenhalgh J.

Syst Rev. 2019 Jan 12;8(1):20. doi: 10.1186/s13643-018-0911-6.

29.

Cost-effectiveness of home blood pressure telemonitoring and case management in the secondary prevention of cerebrovascular disease in Canada.

Padwal RS, So H, Wood PW, Mcalister FA, Siddiqui M, Norris CM, Jeerakathil T, Stone J, Valaire S, Mann B, Boulanger P, Klarenbach SW.

J Clin Hypertens (Greenwich). 2019 Feb;21(2):159-168. doi: 10.1111/jch.13459. Epub 2018 Dec 20.

30.

Recommendations on screening for breast cancer in women aged 40-74 years who are not at increased risk for breast cancer.

Klarenbach S, Sims-Jones N, Lewin G, Singh H, Thériault G, Tonelli M, Doull M, Courage S, Garcia AJ, Thombs BD; Canadian Task Force on Preventive Health Care.

CMAJ. 2018 Dec 10;190(49):E1441-E1451. doi: 10.1503/cmaj.180463. No abstract available.

31.

Renal Function, Albuminuria, and the Risk of Cardiovascular Events After Kidney Transplantation.

Lam NN, Klarenbach S, Quinn RR, Hemmelgarn B, Tonelli M, Ye F, Ravani P, Bello AK, Brennan DC, Lentine KL.

Transplant Direct. 2018 Sep 6;4(10):e389. doi: 10.1097/TXD.0000000000000828. eCollection 2018 Oct.

32.

Association of Angiotensin-Converting Enzyme Inhibitor or Angiotensin Receptor Blocker Use With Outcomes After Acute Kidney Injury.

Brar S, Ye F, James MT, Hemmelgarn B, Klarenbach S, Pannu N; Interdisciplinary Chronic Disease Collaboration.

JAMA Intern Med. 2018 Dec 1;178(12):1681-1690. doi: 10.1001/jamainternmed.2018.4749.

33.

Financial Costs Incurred by Living Kidney Donors: A Prospective Cohort Study.

Przech S, Garg AX, Arnold JB, Barnieh L, Cuerden MS, Dipchand C, Feldman L, Gill JS, Karpinski M, Knoll G, Lok C, Miller M, Monroy M, Nguan C, Prasad GVR, Sarma S, Sontrop JM, Storsley L, Klarenbach S; Donor Nephrectomy Outcomes Research (DONOR) Network.

J Am Soc Nephrol. 2018 Dec;29(12):2847-2857. doi: 10.1681/ASN.2018040398. Epub 2018 Nov 7.

34.

Dialysis Modalities for the Treatment of End-Stage Kidney Disease: A Health Technology Assessment [Internet].

Sinclair A, Cimon K, Loncar M, Sood M, Komenda P, Severn M, Klarenbach S, So H, Tsoi B, Quinn R, Pauly R, Tonelli M, Manns B, Rader T, Moulton K, Moulton K, Helis E, Crain J, Pullman D.

Ottawa (ON): Canadian Agency for Drugs and Technologies in Health; 2017 Mar.

35.

Barriers and facilitators for implementation of electronic consultations (eConsult) to enhance specialist access to care: a scoping review protocol.

Osman MA, Schick-Makaroff K, Thompson S, Featherstone R, Bialy L, Kurzawa J, Okpechi IG, Habib S, Shojai S, Jindal K, Klarenbach S, Bello AK.

BMJ Open. 2018 Sep 28;8(9):e022733. doi: 10.1136/bmjopen-2018-022733.

36.

Follow-up Care of Living Kidney Donors in Alberta, Canada.

Lam NN, Lentine KL, Hemmelgarn B, Klarenbach S, Quinn RR, Lloyd A, Gourishankar S, Garg AX.

Can J Kidney Health Dis. 2018 Jul 26;5:2054358118789366. doi: 10.1177/2054358118789366. eCollection 2018.

37.

Healthcare Costs for the Evaluation, Surgery, and Follow-Up Care of Living Kidney Donors.

Habbous S, Sarma S, Barnieh LJ, McArthur E, Klarenbach S, Manns B, Begen MA, Lentine KL, Garg AX; Donor Nephrectomy Outcomes Research (DONOR) Network.

Transplantation. 2018 Aug;102(8):1367-1374. doi: 10.1097/TP.0000000000002222.

PMID:
30044364
38.

Hospitalizations in Dialysis Patients in Canada: A National Cohort Study.

Molnar AO, Moist L, Klarenbach S, Lafrance JP, Kim SJ, Tennankore K, Perl J, Kappel J, Terner M, Gill J, Sood MM.

Can J Kidney Health Dis. 2018 Jun 1;5:2054358118780372. doi: 10.1177/2054358118780372. eCollection 2018.

39.

Cost-effectiveness of using kidneys from hepatitis C nucleic acid test-positive donors for transplantation in hepatitis C-negative recipients.

Kadatz M, Klarenbach S, Gill J, Gill JS.

Am J Transplant. 2018 Oct;18(10):2457-2464. doi: 10.1111/ajt.14929. Epub 2018 Jun 14.

40.

Screening for impaired vision in community-dwelling adults aged 65 years and older in primary care settings.

Wilson BJ, Courage S, Bacchus M, Dickinson JA, Klarenbach S, Jaramillo Garcia A, Sims-Jones N, Thombs BD; Canadian Task Force on Preventive Health Care.

CMAJ. 2018 May 14;190(19):E588-E594. doi: 10.1503/cmaj.171430. No abstract available.

41.

Health care costs for the evaluation, surgery, and follow-up care of living kidney donors.

Habbous S, Sarma S, Barnieh L, McArthur E, Klarenbach S, Manns B, Begen MA, Lentine KL, Garg AX; Donor Nephrectomy Outcomes Research (DONOR) Network.

Transplantation. 2018 Apr 19. doi: 10.1097/TP.0000000000002222. [Epub ahead of print]

PMID:
29677068
42.

Validation of Living Donor Nephrectomy Codes.

Lam NN, Lentine KL, Klarenbach S, Sood MM, Kuwornu PJ, Naylor KL, Knoll GA, Kim SJ, Young A, Garg AX.

Can J Kidney Health Dis. 2018 Apr 9;5:2054358118760833. doi: 10.1177/2054358118760833. eCollection 2018.

43.

Concentrations of Trace Elements and Clinical Outcomes in Hemodialysis Patients: A Prospective Cohort Study.

Tonelli M, Wiebe N, Bello A, Field CJ, Gill JS, Hemmelgarn BR, Holmes DT, Jindal K, Klarenbach SW, Manns BJ, Thadhani R, Kinniburgh D; Alberta Kidney Disease Network.

Clin J Am Soc Nephrol. 2018 Jun 7;13(6):907-915. doi: 10.2215/CJN.11451017. Epub 2018 Mar 29.

44.

Duration of Living Kidney Transplant Donor Evaluations: Findings From 2 Multicenter Cohort Studies.

Habbous S, Arnold J, Begen MA, Boudville N, Cooper M, Dipchand C, Dixon SN, Feldman LS, Goździk D, Karpinski M, Klarenbach S, Knoll GA, Lam NN, Lentine KL, Lok C, McArthur E, McKenzie S, Miller M, Monroy-Cuadros M, Nguan C, Prasad GVR, Przech S, Sarma S, Segev DL, Storsley L, Garg AX; Donor Nephrectomy Outcomes Research (DONOR) Network.

Am J Kidney Dis. 2018 Oct;72(4):483-498. doi: 10.1053/j.ajkd.2018.01.036. Epub 2018 Mar 24.

45.

A population-based cohort study defines prognoses in severe chronic kidney disease.

Tonelli M, Wiebe N, James MT, Klarenbach SW, Manns BJ, Ravani P, Strippoli GFM, Hemmelgarn BR; Alberta Kidney Disease Network.

Kidney Int. 2018 May;93(5):1217-1226. doi: 10.1016/j.kint.2017.12.013. Epub 2018 Mar 7.

PMID:
29525394
46.
47.

Health care costs associated with hospital acquired complications in patients with chronic kidney disease.

Bohlouli B, Jackson T, Tonelli M, Hemmelgarn B, Klarenbach S.

BMC Nephrol. 2017 Dec 28;18(1):375. doi: 10.1186/s12882-017-0784-2.

48.

Catheter-related blood stream infections in hemodialysis patients: a prospective cohort study.

Thompson S, Wiebe N, Klarenbach S, Pelletier R, Hemmelgarn BR, Gill JS, Manns BJ, Tonelli M; Alberta Kidney Disease Network.

BMC Nephrol. 2017 Dec 8;18(1):357. doi: 10.1186/s12882-017-0773-5.

49.

Direct and indirect costs incurred by Australian living kidney donors.

Barnieh L, Kanellis J, McDonald S, Arnold J, Sontrop JM, Cuerden M, Klarenbach S, Garg AX, Boudville N; Donor Nephrectomy Outcomes Research (DONOR) Network.

Nephrology (Carlton). 2018 Dec;23(12):1145-1151. doi: 10.1111/nep.13205.

PMID:
29215180
50.

The population-level costs of immunosuppression medications for the treatment of glomerulonephritis are increasing over time due to changing patterns of practice.

Barbour S, Lo C, Espino-Hernandez G, Sajjadi S, Feehally J, Klarenbach S, Gill J.

Nephrol Dial Transplant. 2018 Apr 1;33(4):626-634. doi: 10.1093/ndt/gfx185.

PMID:
29106654

Supplemental Content

Loading ...
Support Center